[Action of domperidone on dopamine-induced inhibition of gastric secretion].
The inhibitory action of dopamine on basal gastric secretion and that stimulated by pentagastrin with previous administration of domperidone in 26 male patients, between 18 and 48 years of age, suffering duodenal ulcer has been studied. The administration of domperidone (0.25 mg/kg) produces a significant reduction of the inhibitory action of dopamine on basal gastric secretion and that stimulated by pentagastrin at dose 0.15 microgram/kg/h. Besides dopamine shows a minor, non significant, inhibitory action on acid gastric secretion stimulated by maximal doses of pentagastrin, while showing no differences against the group without administration of domperidone.
D000293:Adolescent; D000328:Adult; D004294:Domperidone / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004381:Duodenal Ulcer / Q000503:physiopathology; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010418:Pentagastrin / Q000494:pharmacology
D018492:Dopamine Antagonists; D004294:Domperidone; D010418:Pentagastrin
Acción de la domperidona sobre la inhibición de la secreción gástrica provocada por la dopamina.